Online inquiry

IVTScrip™ mRNA-Human ARL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28632MR)

This product GTTS-WK28632MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL1 protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001177.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 400
UniProt ID P40616
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28632MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK23234MR IVTScrip™ mRNA-Human ARL13B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK19743MR IVTScrip™ mRNA-Human ANLN, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANLN
GTTS-WK25055MR IVTScrip™ mRNA-Human ARMC4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARMC4
GTTS-WK10597MR IVTScrip™ mRNA-Human AC133, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AC133
GTTS-WK27455MR IVTScrip™ mRNA-Human ARMC4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARMC4
GTTS-WK9244MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRG6
GTTS-WK25609MR IVTScrip™ mRNA-Human ARHGEF12, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF12
GTTS-WK27146MR IVTScrip™ mRNA-Human ARL6, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARL6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →